How Congress Could Expand Medicare Benefits to Cover Dental, Hearing and Vision
How Congress Could Expand Medicare Benefits to Cover Dental, Hearing and Vision Democrats have included the proposal for the new [...]
Press Release : Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research
-- The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise [...]
EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs
Provides roadmap to commercial agreement based on shared objective to secure patient access to innovative and cost-effective cancer medicines Agreement [...]
Collaborative RWE Registry Promises Data Transparency
The Real World Evidence (RWE) Registry was formed by the International Society for Pharmacoeconomics and Outcomes (ISPOR), the International Society for [...]
New Ideagen Whitepaper on Data Integrity in the Life Sciences
Ideagen has published a whitepaper on maintaining data integrity in your life sciences organization. The paper includes important insights on [...]
[Podcast] Merck Marketing Expert Discusses AI in Oncology Care
In a recent episode of Life Science Marketing Radio, Chris Conner interviewed Hemal Somaiya, Global Brand Lead for Oncology at [...]
Mark Cuban Enters Convoluted PBM Market, Promises Lower Prescription Drug Prices
Two new groups have entered the pharmacy benefit manager (PBM) market: Mark Cuban and a coalition of employers. The Mark [...]
Eli Lilly CEO Shares Thoughts on How Medicare Pricing Measures Could Impact Innovation
Eli Lilly CEO David Ricks shared his thoughts on how policies intended to lower drug prices would negatively impact pharmaceutical [...]
Newly Launched Cerner Enviza Utilizes RWD to Advance R&D, Improve Patient Outcomes, and Reduce Healthcare Costs
Cerner has launched Cerner Enviza, an operating unit that will use real world data (RWD) to advance clinical research and improve [...]
Savana CEO and Founder Discusses Overcoming RWE Challenges and Ensuring Data Privacy
Savana CEO and Founder discussed challenges that arise when designing real world evidence (RWE) studies, including data privacy concerns, data [...]
RWE Brings Data Privacy Concerns and Solutions
The use of real world evidence (RWE) has put a spotlight on data privacy and regulatory concerns. Regulatory expert Jackie [...]
Investigators Use RWD to Identify Potential Alzheimer’s Drug
According to a new study using data from electronic health records (EHRs), bumetanide, a diuretic, could be used in patients [...]
RWD Study Finds Association Between High BMI and COVID-19 Risk
Researchers used Swedish real world data (RWD) to understand risk factors linked to poor COVID-19 outcomes. The investigators identified a [...]
IQVIA RWE Expert Discusses Trust, COVID-19, and FDA Framework
IQVIA’s Chirag Ghai recently shared his thoughts on real world evidence (RWE), its use in addressing brought by the COVID-19 [...]
Four Health Strategies Help Employers Reduce Costs
A new article highlights four approaches that can help forward-looking employers reduce the costs of healthcare. These strategies include advanced [...]
Whitepaper Highlights the Benefits of Digital Data Collection
Signant Health has published a whitepaper that compares digital data collection with manual methods. A growing number of clinical trial [...]
Three Decades of Democratic Drug Price Control Efforts Face Uncertainty
More than thirty years of drug price regulation efforts by Democrats are facing uncertainty as efforts to pass legislation allowing [...]
ISPOR Article on the Growing Wearable Market and New Applications in Healthcare
A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an [...]
HealthVerity’s RWD Platform Informs Government Response to COVID-19
HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 [...]
Sumitomo Dainippon Pharma and BehaVR announce landmark deal for multiple virtual reality digital therapeutics
OSAKA , Japan and NASHVILLE, Tenn. Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan ; Representative Director, President and [...]
Register Now for Upcoming October Webinar on RWE in Regulatory Filings
Flatiron Health will hold a webinar detailing how real world evidence (RWE) can be used in regulatory findings. The webinar [...]
EURIPID Survey Shines Spotlight on Drug Price Transparency and Confidential Payer-Pharma Agreements
A recent article, published in Health Policy, highlights the use of confidential managed-entry agreements (MEAs) between payers and pharma throughout [...]
ISPOR Director Discusses Global Commitment to Improving HEOR
Director of Global Networks at the International Society for Pharmacoeconomics and Outcomes (ISPOR) Robert Selby discussed ISPOR’s worldwide initiative intended to [...]
Pear Launches PDT Digest, Highlights the Power of Digital Tools in Improving Patient Outcomes and Reducing Costs
Pear Therapeutics recently launched the Prescription Digital Therapeutics (PDT) Digest, intended to showcase the value of digital tools in improving [...]
ICER’s Final Evidence Report for Two Myasthenia Gravis Therapies Now Available
The Institute for Clinical and Economic Review (ICER) has published its final evidence report for two drugs used to treat [...]